Does Flow During Rest and Relaxation Suffice?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Samady, Habib & Gogas, Bill D.
Journal of the American College of Cardiology Vol. 61, No. 13, 2013
© 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.035EDITORIAL COMMENT
Does Flow During Rest and
Relaxation Suffice?*
Habib Samady, MD, Bill D. Gogas, MD
Atlanta, Georgia
Andreas Gruentzig first reported that a pressure gradient
15 mm Hg after percutaneous coronary angioplasty is
associated with a lower risk of restenosis (1). Several years
later, in the mid 1980s, Pijls et al. (2) and Tonino et al. (3)
introduced fractional flow reserve (FFR), defined as the
ratio of stenotic to normal coronary flow. Subsequently, 3
landmark trials have provided evidence for the utility of
FFR in directing coronary revascularization. First, the
DEFER (Deferral versus performance of PTCA based on
coronary pressure derived fractional flow reserve) study
demonstrated the long-term safety of deferring percutane-
ous coronary intervention (PCI) in patients with FFR
0.75 (2). Second, the FAME (Fractional Flow Reserve
See pages 1409, 1421, and 1428
Versus Angiography for Multivessel Evaluation) trial dem-
onstrated superiority and cost effectiveness of FFR-guided
PCI with drug-eluting stent (DES) implantation over
angiographically guided PCI with DES in patients with
multivessel disease (4,5). Third, the FAME-2 study showed
that performing PCI with DES in lesions with FFR 0.80
in addition to medical therapy in patients with stable
coronary artery disease resulted in a significant reduction in
major adverse cardiac events compared to medical therapy
alone (3). Furthermore, data from the FAME study show
that as many as 20% of lesions with diameter stenosis 71%
to 90% are functionally nonsignificant (6). Therefore, it
could be argued that all patients with stable coronary artery
disease and 40% to 90% of lesions without noninvasive
evidence of ischemia in the corresponding myocardial bed
should undergo FFR evaluation. Yet FFR performance rates
in catheterization laboratories remain low, merely 7% of
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those undergoing PCI (7,8).
What are the impediments to greater FFR performance?
First, are lingering doubts about discordance between visual
diameter stenosis and observed FFR values, resulting in the
all-too-entrenched occulostenotic reflex. Second, are the
expectations from patients and referring physicians, as well
as incentives to perform revascularization. And third, are
certain practical considerations that might dissuade some
operators from performing FFR, such the necessity to
administer intravenous adenosine that results in frequent,
albeit transient, side effects of chest pain, shortness of
breath, flushing (9), or high-degree atrioventricular block, as
well as significant added cost. Although these practical
aspects of FFR measurement are not considered limiting by
FFR proponents, they likely create sufficient grounds for
many interventional cardiologists to delay adoption of phys-
iologic testing. Of these impediments to greater perfor-
mance of FFR, continued education and increasing empha-
sis on evidence-based cost-effective care will likely erode the
occulostenotic reflex and reduce financial incentives to
perform unnecessary revascularization; and attempts to
eliminate perceived practical barriers might result in more
widespread adoption of invasive physiologic testing. Indeed,
several recently instituted practical shortcuts have resulted in
greater utilization of intravascular assessment techniques,
including the wireless PressureWire Certus (St. JudeMedical, St.
Paul, Minnesota), intracoronary ultrasound systems inte-
grated within the consoles of the catheterization laboratories
and the “plug-and-go” set-up of the SmartMap Pressure
Instrument (Volcano, Cordova, California).
In an effort to further simplify physiologic testing, 2
hyperemia-free–based physiologic indices of epicardial le-
sion severity have recently been introduced: basal stenosis
resistance (10) and instantaneous wave-free ratio (iFR) (11).
Although basal stenosis resistance has been shown to have
similar diagnostic accuracy to FFR for identifying ischemia
on myocardial perfusion imaging, it involves the use of a
combined pressure and velocity wire, which introduces
variability in measurement and complexity, and therefore
has not been clinically adopted. The other hyperemia-free
novel index, iFR, is even easier than FFR to measure, and
hence has immediate appeal if clinically validated. It is
defined as the resting ratio of distal to proximal translesional
pressure during a finite period in diastole (the wave-free
period) and is based on the assumption that mean resting
myocardial resistance is equivalent to the mean hyperemic
resistance over the complete cardiac cycle.
The first multicenter study, ADVISE (Adenosine Vaso-
dilator Independent Stenosis Evaluation), compared iFR to
FFR in 157 intermediate lesions and found the diagnostic
accuracy of iFR to be 90%, with an optimal iFR cut-off of
0.90 (11). However, several leading FFR investigators have
raised concerns about the concepts underpinning iFR, the
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addition, they have argued that: 1) the premise for accurate
FFR measurement hinges on induction of maximal hyper-
emia, when pressure accurately reflects flow, allowing FFR
to be calculated as the ratio of mean distal coronary pressure
to the mean aortic pressure; 2) myocardial resistance cannot
be minimal and constant at rest, even during a finite period
in diastole; and 3) while the correlation between iFR and
FFR may be good at the extremes of FFR, it is poor in the
clinically relevant FFR range of 0.60 to 0.90. Therefore,
controversy rages regarding the potential value of iFR for
lesion assessment.
In this issue of the Journal, 3 papers address the comparison
f iFR to FFR. In the first paper, Berry et al. (12) investigated
he diagnostic accuracy of iFR using FFR as the gold standard
n 206 consecutive patients referred for PCI as well as in a
etrospective dataset of 500 patients. They found the overall
iagnostic accuracy of iFR to be 60% (95% confidence interval:
3% to 67%) for predicting FFR 0.80 and only 51% (95%
onfidence interval: 43% to 59%) within the clinically relevant
FR range of 0.60 to 0.90. The researchers also found that the
FR value changed significantly between resting and hyperemic
onditions and that the diagnostic accuracy of iFR was no
etter than that of resting distal to aortic pressure ratio (Pd/Pa).
They conclude that iFR correlates weakly with FFR and is not
independent of hyperemia.
The second paper by Johnson et al. (13), also investigated
the relationship between iFR and FFR in 1,129 clinical
pressure tracings acquired from several centers and 1,000
observations from a Monte Carlo simulation (which is
performed by repeatedly selecting random parameters using
the reported ranges of these physiologic variables). These
investigators found that mean iFR value was 0.09 higher
than mean FFR with 0.17 limits of agreement; that
diastolic resting resistance (during both the wave-free pe-
riod or during entire diastole) was 2.5-fold higher than
mean hyperemic resistance (4.84  2.55 mm Hg/[cm/s] vs.
2.06  0.83 mm Hg/[cm/s], p  0.001) in 120 patients in
whom both pressure and velocity data were available; and
that classic pressure-flow physiology explained the iFR and
FFR relationship completely without invoking wave me-
chanics (13), leading them to conclude that iFR should not
be used interchangeably with FFR.
The third paper by Sen et al. (14), the ADVISE study
investigators, compared iFR, iFRa (adenosine iFR), and
FFR to hyperemic stenosis resistance index (HSR), a
combined pressure-and-flow index that is an excellent
predictor of ischemia (with limited clinical use due to the
need for simultaneous pressure and flow measurements).
They found that the agreement between diagnostic classi-
fication of iFR and FFR was 47 or 51 lesions, or 93%. They
report that among the 4 of 51 patients with disagreements
between iFR and FFR, HSR agreed with each index twice,
and that there were no significant differences in the diag-
nostic accuracy of iFR (93%, with a 0.86 iFR threshold),
iFRa (94%, with a 0.66 iFRa threshold), and FFR (96%, tith a 0.75 FFR threshold; p  0.48). They also found that
icrovascular resistance was 39% lower in the wave-free
eriod than during the entire cardiac cycle at rest but was
igher than during the entire cardiac cycle during hyper-
mia. The researchers conclude that iFR and FFR have
quivalent agreement with classification of coronary stenosis
everity by HSR and that the diagnostic categorization by
FR was not improved by the administration of adenosine,
ndicating that iFR can be used as an adenosine-free
lternative to FFR.
How can the first 2 studies demonstrate such different
esults from the third, and where do these studies leave the
ctive debate regarding the potential value of iFR?
Given that the crux of the debate revolves around whether
yocardial resistance can be minimal and/or constant at rest
uring the wave-free period, let us address this issue first. The
FR is defined as the ratio of stenotic to normal flow, and
ased on Ohm’s Law (P  flow  resistance) and the
definition of FFR (stenotic divided by normal flow), resistance
would need to be cancelled from both the numerator and the
denominator for pressure to be proportional to flow. Thus,
resistance would have to be both minimal and constant to be
cancelled without significantly changing the ratio. Recall that
Johnson et al. (13) found that diastolic wave-free resting
resistance was 2.5-fold higher than mean hyperemic resistance,
whereas Sen et al. (14) found minimal difference between
diastolic wave-free resting resistance and whole-cycle mean
hyperemic resistance. In the latter study, among patients with
physiologically unobstructed arteries (HSR0.8 mmHg·cm/s),
FFR had greater reduction in intracoronary resistance from
baseline than when calculated solely during the rest diastolic
wave-free period compared to iFR (FFR 53% vs. iFR 36%,
p  0.001).
The clinical correlate of this observation is when a
minimal resting gradient across a proximal lesion increases
dramatically after hyperemia, resulting in a significant FFR.
It is known that a small subgroup of patients may have
discordance between a minimal rest gradient, a normal
coronary flow velocity reserve, a nonischemic HSR, and an
ischemic FFR. Is it possible that this small cohort of
patients represents a situation where coronary flow is in-
creased so much due to the very large autoregulatory reserve
that a “pseudo” gradient can be produced across a minimal
epicardial lesion akin to what can be observed across a
relatively normal aortic valve in hyperdynamic states such as
aortic regurgitation, anemia, or hyperthyroidism? Interest-
ingly, among patients with physiologically obstructed arter-
ies (HSR0.8 mm Hg·cm/s), Sen et al. (14) found that the
all in microvascular resistance was similar for FFR and iFR
FFR 34% and iFR 45%, p  0.17). The differential
esponse of the microvasculature in obstructive versus non-
bstructive vessels may relate to the necessary recruitment of
he autoregulatory reserve at rest in obstructed arteries to
aintain distal myocardial blood flow, not leaving a large
utoregulatory reserve (or decrease in microvascular resis-
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tory reserve is intact, with flow augmenting threefold to
fivefold with hyperemia, thereby significantly lowering re-
sistance. Despite these differences in observed resistance
between the various indices, the accurate categorization of
lesions was not significantly different among indices. John-
son et al. (13) did not report resistance in obstructive vessels
versus not obstructive vessels, and both intravenous and
varying doses of intracoronary adenosine were administered,
perhaps introducing another variable in the degree of
microvascular vasodilation induced.
On the question of how constant or varied resistance
was with the different indices, Sen et al. (14) found that
the variance in resistance reduction was greater during FFR
(5.0%) than either iFR (1.9%) or iFRa (2.1%, p  0.001 for
oth) in both physiologically unobstructed and obstructed
essels. Therefore, although neither of the those studies
ere primarily designed to evaluate the magnitude or
ariability of microvascular resistance during various phar-
acologic manipulations, it would seem that resistance is
ore often lower throughout the whole cardiac cycle during
yperemia than in the wave-free period at rest (particularly
n hemodynamically nonobstructed lesions), but that resis-
ance may be more constant at rest during the wave-free
eriod than during hyperemia due to various levels of resting
utoregulatory tone and varying dosage of vasodilator.
herefore, theoretically cancelling resistance from the nu-
erator and denominator of either the FFR or iFR formula
oes influence the relationship between pressure and flow
nd impacts the value of both physiologic indices. By
easuring the pressure ratio during sustained and minimal
yperemia, FFR likely provides a more robust assessment of
esion severity across the whole spectrum of epicardial
tenosis.
Another potential difference between the first 2 papers
nd the third paper involves the methodology of iFR
alculation. Sen et al. (14) state that there is proprietary
lgorithm sequence provided by Volcano that allows appro-
riate phase shifting of paired distal and proximal pressure
uring the wave-free period that was not available to Berry
t al. (12) and Johnson et al. (13). The recently presented
ESOLVE (A Multicenter Study Evaluating the Diagnos-
ic Accuracy of iFR Compared to FFR) was an independent
nalysis of iFR, rest Pd/Pa, and FFR in 1,548 lesions from
different cohorts using the proprietary algorithm (15). The
nvestigators found a diagnostic accuracy of iFR to predict
n FFR 0.80 to be 80%, not quite as high as the 90%
escribed by the ADVISE investigators, yet much higher
han the 60% reported by Berry et al. (12). The RESOLVE
nvestigators also found that using a hybrid iFR-FFR
pproach (i.e., administration of adenosine when iFR is
ithin an intermediate zone), they achieved a 95% classifi-
ation match with FFR, reducing adenosine use by 57%.
nterestingly, although the diagnostic accuracy of rest
d/Pa was very similar to iFR, a hybrid rest Pd/Pa-FFR
pproach resulting in only a 24% reduction in adenosinesage. It would thus appear that the details of the
ethodology for calculating iFR might impact its accu-
ate measurement (16).
Undoubtedly, the significant body of evidence supporting
ts use has propelled FFR into a major clinical tool for
irecting coronary revascularization in the cardiac catheter-
zation laboratory. In aggregate, the present data suggest
hat iFR has an 80% diagnostic accuracy (range of 60% to
0% in various studies) for detecting FFR 0.80, although
ts diagnostic accuracy may be lower in intermediate and
onobstructed lesions than in severe lesions. That should be
aken in the context of a nonperfect reproducibility of any
hysiologic test, including the gold standard of FFR. The
elatively similar performance of FFR and iFR against HSR
s intriguing and highlights the critical importance of the
old standard chosen. Even if iFR is inferior to FFR, it
ikely has incremental diagnostic value over visual angio-
raphic lesion assessment, and if more widely adopted in
ieu of visual assessment due to its simplicity may result in
ore appropriate revascularization decisions. The concept
f a hybrid iFR-FFR strategy, on the one hand, seems
ppealing and the best of all worlds but, on the other hand,
ay eliminate the very simplicity and time-saving advan-
ages that iFR is designed to achieve.
Ultimately, these invasive physiologic tests are primarily
ndicated for evaluation of patients with chronic coronary
rtery disease in whom the impact of revascularization is
argely to improve symptoms and perhaps to reduce urgent
evascularization (5), but not to prevent death or myocardial
nfarction. Therefore, misclassification of a minority of
ntermediate coronary lesions will likely not have a dramatic
dverse outcome. The introduction of iFR has stirred a
igorous debate in the invasive physiology community about
hether to stay entirely focused on continued educational
nd research efforts to increase adoption of FFR or whether
o embrace further evaluation of the simpler vasodilator-free
hysiologic index that might be more suited to the inter-
entional cardiology temperament, albeit with limitations.
hether iFR or hybrid iFR-FFR–guided outcome studies
imilar to DEFER, FAME, and FAME 2 are performed
epends on a modicum of consensus in the physiology
ommunity on this question: Does flow at rest and relax-
tion suffice?
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